• Citer

Trastuzumab-associated cardiac events at 8 years of median follow-up in the herceptin adjuvant trial (BIG 1-01)

par de Azambuja, Evandro ;Piccart-Gebhart, Martine ;Procter, Marion;Agbor‑Tarh, Dominique;Cameron, David A;Smith, Ian;Dowsett, Mitch;Van Veldhuisen, Dirk Jan;Metzger-Filho, Otto;Gelber, Richard;Steinseifer, Jutta;Suter, Thomas;Untch, Michael;Jackisch, Christian;Gianni, Luca;Baselga, José;Bell, Richard;Leyland-Jones, Brian
Référence Journal of clinical oncology, 32, 20, page (2159-2165)
Publication Publié, 2014-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	Trastuzumab-associated cardiac events at 8 years of median follow-up in the herceptin adjuvant trial (BIG 1-01)
Auteur:	de Azambuja, Evandro; Piccart-Gebhart, Martine; Procter, Marion; Agbor‑Tarh, Dominique; Cameron, David A; Smith, Ian; Dowsett, Mitch; Van Veldhuisen, Dirk Jan; Metzger-Filho, Otto; Gelber, Richard; Steinseifer, Jutta; Suter, Thomas; Untch, Michael; Jackisch, Christian; Gianni, Luca; Baselga, José; Bell, Richard; Leyland-Jones, Brian
Informations sur la publication:	Journal of clinical oncology, 32, 20, page (2159-2165)
Statut de publication:	Publié, 2014-07
Sujet CREF:	Cancérologie
MeSH keywords:	Adult
	Aged
	Antibodies, Monoclonal, Humanized -- administration & dosage -- adverse effects
	Antineoplastic Agents -- administration & dosage -- adverse effects
	Breast Neoplasms -- chemistry -- drug therapy -- pathology -- surgery
	Chemotherapy, Adjuvant
	Drug Administration Schedule
	Female
	Follow-Up Studies
	Heart Failure -- chemically induced
	Humans
	Incidence
	Logistic Models
	Mastectomy, Segmental
	Middle Aged
	Neoplasm Staging
	Radiotherapy, Adjuvant
	Receptor, ErbB-2 -- analysis
	Tumor Markers, Biological -- analysis
	Ventricular Function, Left -- drug effects
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2013.53.9288
	info:pii/JCO.2013.53.9288
	info:scp/84905858933
	info:pmid/24912899